Closed System Transfer Devices Market to Observe Notable Growth Due to Increase in Use of Oncology Drugs and Emergence of Novel Protocols in Pharmaceutical Industry, Says TMR

ALBANY, N.Y., Nov. 23, 2021 /PRNewswire/ -- The growing adoption of closed system transfer devices in a plethora of drug safety programs coupled with increase in utilization of oncology drugs s expected to fuel the growth of the closed system transfer devices (CSTD) market. The emergence of several regions as cancer research centers is expected to be growth accelerators for the closed system transfer devices market during the forecast period of 2020-2030. ALBANY, N.Y.,Nov. 23, 2021...

ALBANY, N.Y., 23/11/2021 (informazione.news - comunicati stampa - editoria e media)

ALBANY, N.Y. , Nov. 23, 2021 /PRNewswire/ -- The growing adoption of closed system transfer devices in a plethora of drug safety programs coupled with increase in utilization of oncology drugs s expected to fuel the growth of the closed system transfer devices (CSTD) market. The emergence of several regions as cancer research centers is expected to be growth accelerators for the closed system transfer devices market during the forecast period of 2020-2030.

Transparency Market Research (TMR) has conducted extensive research on various aspects associated with the growth of the closed system transfer devices (CSTD) market. Analysts at TMR expect the global market for closed system transfer devices (CSTD) to expand at a CAGR of 10.9% during the forecast period. The closed system transfer devices (CSTD) market was valued at US$ 764.7 Mn in 2019 and extrapolated to cross US$ 2.37 Bn by 2030.

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=55230

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=55230

The incidence of cancer is rising at an accelerated rate. Chemotherapy is an important component in many cancer treatments. During chemotherapy, drugs such as doxorubicin are used. Such drugs are harmful to the persons who handle them. Frequent exposure could result in hair loss, infertility, birth defects, and cancer. In order to assure complete safety and avoid side-effects, safe handling is the key. Hence, this aspect ultimately maximizes the demand for closed system transfer devices.

 - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=55230

In this study, the closed system transfer devices (CSTD) market has been classified into five regions: Asia Pacific , Latin America , North America , Europe , and Middle East & Africa . According to TMR, North America is expected to lead the closed system transfer devices (CSTD) market. The Exposure of healthcare workers to harmful and toxic drugs has increased considerably over the years. The Centers for Diseases Control and Prevention (CDC) estimates that approximately 8 million healthcare workers in North America are exposed to harmful drugs. Thus, these statistics reveal the need for safe drug transfer mechanisms. This factor eventually helps in increasing the growth rate of the closed system transfer devices (CSTD) market in North America .

https://www.transparencymarketresearch.com/checkout.php?rep_id=55230&ltype=S  

Asia Pacific is also expected to witness steady growth during the forecast period. China may emerge as the largest growth-generating country in the Asia Pacific region. An increase in the target population requiring treatment and expansive utilization of closed system transfer devices in China is projected to drive the market in Asia Pacific .

Some well-established players in the closed system transfer devices (CSTD) market are Dickinson and Company, ICU Medical, Inc., Corvida Medical, JMS Co. Ltd., Equashield LLC, and Becton.

Biologics Contract Manufacturing Market: Companies in the biologics contract manufacturing market are entering into multiple collaborations to increase the availability of ublituximab and enable its commercialization. Companies are re-evaluating their supply needs and securing long-term capacity to meet the global demand for ublituximab.

Bioanalytical Services Market: The bioanalytical services market is expected to advance at a CAGR of   during the forecast period. Pharmaceutical companies are increasing their output capacities in pre-clinical testing methods, drug safety, etc. with changing guidelines of international organizations.

Enteral Feeding Devices Market: Companies in the enteral feeding devices market are increasing the research in systems consisting of an electro-mechanical device with embedded software and enteral feeding tubes. They are increasing efforts to leverage the power of the electromagnetic technology where the devices create a personalized body map of patients, thus allowing the medical staff to precisely place the tube in the stomach or small intestine through the oral or nasoenteric route.

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

 https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
USA - Canada Toll Free: 866-552-3453
sales@transparencymarketresearch.com
: Twitter | LinkedIn
: https://tmrblog.com
https://www.transparencymarketresearch.com/pressrelease/closed-system-transfer-device-market.htm 

Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg